Masimo Pre-Tax Profit Margin 2010-2024 | MASI
Current and historical pre-tax profit margin for Masimo (MASI) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Masimo pre-tax profit margin for the three months ending September 30, 2024 was .
| Masimo Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2024-09-30 | $2.04B | $0.08B | 3.92% |
| 2024-06-30 | $2.02B | $0.08B | 4.07% |
| 2024-03-31 | $1.98B | $0.09B | 4.40% |
| 2023-12-31 | $2.05B | $0.09B | 4.30% |
| 2023-09-30 | $2.12B | $0.12B | 5.72% |
| 2023-06-30 | $2.19B | $0.16B | 7.27% |
| 2023-03-31 | $2.30B | $0.16B | 7.01% |
| 2022-12-31 | $2.04B | $0.19B | 9.53% |
| 2022-09-30 | $1.75B | $0.22B | 12.31% |
| 2022-06-30 | $1.50B | $0.23B | 15.36% |
| 2022-03-31 | $1.24B | $0.27B | 21.62% |
| 2021-12-31 | $1.24B | $0.28B | 22.20% |
| 2021-09-30 | $1.21B | $0.27B | 21.97% |
| 2021-06-30 | $1.18B | $0.26B | 21.92% |
| 2021-03-31 | $1.17B | $0.26B | 21.91% |
| 2020-12-31 | $1.14B | $0.26B | 23.08% |
| 2020-09-30 | $1.10B | $0.26B | 23.79% |
| 2020-06-30 | $1.05B | $0.25B | 24.24% |
| 2020-03-31 | $0.98B | $0.25B | 25.18% |
| 2019-12-31 | $0.94B | $0.23B | 24.92% |
| 2019-09-30 | $0.91B | $0.23B | 24.73% |
| 2019-06-30 | $0.90B | $0.22B | 24.78% |
| 2019-03-31 | $0.88B | $0.22B | 24.94% |
| 2018-12-31 | $0.86B | $0.22B | 25.03% |
| 2018-09-30 | $0.84B | $0.20B | 24.17% |
| 2018-06-30 | $0.83B | $0.20B | 23.85% |
| 2018-03-31 | $0.81B | $0.19B | 23.33% |
| 2017-12-31 | $0.79B | $0.19B | 23.42% |
| 2017-09-30 | $0.78B | $0.46B | 59.13% |
| 2017-06-30 | $0.76B | $0.46B | 60.16% |
| 2017-03-31 | $0.74B | $0.45B | 60.76% |
| 2016-12-31 | $0.71B | $0.43B | 60.87% |
| 2016-09-30 | $0.68B | $0.15B | 21.50% |
| 2016-06-30 | $0.66B | $0.14B | 20.63% |
| 2016-03-31 | $0.65B | $0.13B | 19.63% |
| 2015-12-31 | $0.63B | $0.12B | 18.54% |
| 2015-09-30 | $0.63B | $0.11B | 18.05% |
| 2015-06-30 | $0.62B | $0.11B | 17.50% |
| 2015-03-31 | $0.60B | $0.10B | 16.61% |
| 2014-12-31 | $0.59B | $0.10B | 17.38% |
| 2014-09-30 | $0.57B | $0.08B | 14.64% |
| 2014-06-30 | $0.55B | $0.08B | 14.62% |
| 2014-03-31 | $0.55B | $0.09B | 15.45% |
| 2013-12-31 | $0.55B | $0.08B | 13.92% |
| 2013-09-30 | $0.54B | $0.09B | 15.86% |
| 2013-06-30 | $0.52B | $0.08B | 16.03% |
| 2013-03-31 | $0.51B | $0.08B | 16.27% |
| 2012-12-31 | $0.49B | $0.08B | 17.04% |
| 2012-09-30 | $0.47B | $0.08B | 17.55% |
| 2012-06-30 | $0.46B | $0.08B | 18.12% |
| 2012-03-31 | $0.45B | $0.08B | 18.88% |
| 2011-12-31 | $0.44B | $0.09B | 20.05% |
| 2011-09-30 | $0.43B | $0.09B | 20.79% |
| 2011-06-30 | $0.43B | $0.10B | 22.09% |
| 2011-03-31 | $0.42B | $0.09B | 22.14% |
| 2010-12-31 | $0.41B | $0.11B | 26.35% |
| 2010-09-30 | $0.39B | $0.11B | 26.97% |
| 2010-06-30 | $0.38B | $0.10B | 27.18% |
| 2010-03-31 | $0.36B | $0.10B | 28.10% |
| 2009-12-31 | $0.35B | $0.08B | 23.50% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $8.910B | $2.048B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $207.434B | 25.31 |
| Intuitive Surgical (ISRG) | United States | $194.997B | 101.95 |
| Edwards Lifesciences (EW) | United States | $43.303B | 27.50 |
| Alcon (ALC) | Switzerland | $41.141B | 27.53 |
| IQVIA Holdings (IQV) | United States | $36.894B | 20.33 |
| IDEXX Laboratories (IDXX) | United States | $34.232B | 40.31 |
| DexCom (DXCM) | United States | $30.373B | 45.74 |
| Waters (WAT) | United States | $22.584B | 33.39 |
| STERIS (STE) | Ireland | $20.308B | 23.38 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.662B | 0.00 |
| Hologic (HOLX) | United States | $16.272B | 17.57 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.198B | 13.55 |
| Globus Medical (GMED) | United States | $11.856B | 30.02 |
| Sysmex ADR (SSMXY) | Japan | $11.516B | 36.11 |
| Penumbra (PEN) | United States | $9.619B | 94.22 |
| Glaukos (GKOS) | United States | $8.631B | 0.00 |
| Teleflex (TFX) | United States | $8.110B | 12.93 |
| Inari Medical (NARI) | United States | $4.642B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $4.532B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.486B | 25.42 |
| Veracyte (VCYT) | United States | $3.219B | 96.60 |
| LivaNova (LIVN) | United Kingdom | $2.534B | 14.63 |
| Nihon Kohden (NHNKY) | Japan | $2.370B | 18.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.364B | 0.00 |
| TransMedics (TMDX) | United States | $2.309B | 73.20 |
| Elekta AB (EKTAY) | Sweden | $2.138B | 19.22 |
| Integra LifeSciences Holdings (IART) | United States | $1.683B | 8.79 |
| Alphatec Holdings (ATEC) | United States | $1.414B | 0.00 |
| RxSight (RXST) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.253B | 83.00 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $1.003B | 0.00 |
| Paragon 28 (FNA) | United States | $0.867B | 0.00 |
| AxoGen (AXGN) | United States | $0.794B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.730B | 17.21 |
| IRadimed (IRMD) | United States | $0.717B | 38.76 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.699B | 11.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.650B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.592B | 0.00 |
| SiBone (SIBN) | United States | $0.575B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.575B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.498B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.476B | 25.05 |
| Treace Medical Concepts (TMCI) | United States | $0.455B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.413B | 22.38 |
| ClearPoint Neuro (CLPT) | United States | $0.405B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.367B | 0.00 |
| NeuroPace (NPCE) | United States | $0.356B | 0.00 |
| CVRx (CVRX) | United States | $0.344B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.226B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.215B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.182B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
| Nevro (NVRO) | United States | $0.123B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.114B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.111B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.107B | 11.47 |
| LENSAR (LNSR) | United States | $0.096B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.086B | 0.00 |
| 908 Devices (MASS) | United States | $0.079B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.078B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.074B | 0.00 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| Hyperfine (HYPR) | United States | $0.069B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.061B | 31.57 |
| Baird Medical Investment Holdings (BDMD) | $0.058B | 0.00 | |
| EnVVeno Medical (NVNO) | United States | $0.057B | 0.00 |
| Neuronetics (STIM) | United States | $0.052B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.041B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.039B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Precision Optics (POCI) | United States | $0.030B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.017B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.007B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |